Indaptus Therapeutics Inc
Change company Symbol lookup
Select an option...
INDP Indaptus Therapeutics Inc
FUSN Fusion Pharmaceuticals Inc
RDUS Schnitzer Steel Industries Inc
ALEC Alector Inc
LZM Lifezone Metals Ltd
LMRMF Lomiko Metals Inc
SOXL Direxion Daily Semiconductor Bull 3X Shares
OXSQ Oxford Square Capital Corp
BAER Bridger Aerospace Group Holdings Inc
CMRA Comera Life Sciences Holdings Inc

Health Care : Biotechnology |
Company profile

Indaptus Therapeutics, Inc. is a clinical biotechnology company. The Company is focused on enhancing and expanding curative cancer immunotherapy for patients with unresectable or metastatic solid tumors and lymphomas. It designs its approach by targeting specific tumor or viral antigens. Its lead candidate, Decoy20, through pre-clinical development. Its platform is based on the hypothesis that require anti-tumor immunotherapy to activate both innate and adaptive cellular immunity in both tumors and immune organs. Its approach uses multi-targeted package of bacterial pathogen-associated molecular patterns (PAMPs), in the form of attenuated and killed, intact but non-pathogenic bacteria delivered intravenously. Its intravenous therapeutic candidates target the liver, spleen, and leaky vasculature of tumors, producing immune activation in an immune organ, as well as a common site for primary and metastatic cancer and hepatitis B virus (HBV) infection.

Day's Change
-0.21 (-7.75%)
B/A Size
Day's High
Day's Low
(Below Average)

Today's volume of 26,858 shares is on pace to be lower than INDP's 10-day average volume of 40,136 shares.


Nvidia CEO tells graduates: Take advantage of AI or get left behind

7:54 am ET May 30, 2023 (MarketWatch)

By Mike Murphy

In commencement speech in Taiwan, Jensen Huang tells grads to seize opportunities

Those were the words of Nvidia Corp. founder and Chief Executive Jensen Huang on Saturday, as he gave the commencement address at National Taiwan University in Taipei.

Huang told graduates that businesses and individuals alike need to become familiar with artificial intelligence or risk missing out.

"Agile companies will take advantage of AI and boost their position. Companies less so will perish," he said, according to media reports. "While some worry that AI may take their jobs, someone who's expert with AI will."

Last week, Nvidia stock (NVDA)roared more than 25% higher after a blowout earnings report that predicted a big jump in quarterly revenue, thanks to a boom in chips it sells for AI. Nvidia shares neared an all-time high Friday, as the company closed in on a $1 trillion valuation.

Also read:How the AI boom can affect your money and your career

In his speech Saturday, Huang urged graduates to seize opportunities, but also embrace the inevitable failures they will encounter.

"In 40 years, we created the PC, internet, mobile, cloud and now the AI era. What will you create? Whatever it is, run after it like we did. Run, don't walk," Huang said. "Either you are running for food, or you are running from becoming food."

Huang cited his own company's early stumbles. "At Nvidia, I experienced failures -- great big ones. All humiliating and embarrassing. Many nearly doomed us.... Confronting our mistake and, with humility, asking for help, saved Nvidia."

Calling 2023 "a perfect year to graduate," Huang likened the AI revolution to "the rebirth of the computer industry."

"AI has opened immense opportunities," he said, telling graduates they must "take advantage of AI and do amazing things with an AI copilot by your side."

Also see:Did Nvidia just help create an AI-fueled stock bubble?

-Mike Murphy

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.


(END) Dow Jones Newswires

May 30, 2023 07:54 ET (11:54 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.